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THE ROLE OF E2F1 IN THE RESPONSE TO DNA DOUBLE STRAND
BREAKS
Publication No.
Jie Chen, Ph.D.
Supervisory Professor: David G. Johnson, Ph.D
The importance of E2F transcription factors in the processes of proliferation
and apoptosis are well established. E2F1, but not other E2F family members, is
also phosphorylated and stabilized in response to various forms of DNA damage
to regulate the expression of cell cycle and pro-apoptotic genes. E2F1 also
relocalizes and forms foci at sites of DNA double-strand breaks but the function
of E2F1 at sites of damage is still unknown. Here I reveal that E2F1 deficiency
leads to increased spontaneous DNA break and impaired recovery following
exposure to ionizing radiation. In response to DNA double-strand breaks, NBS1
phosphorylation and foci formation are defective in cells lacking E2F1, but NBS1
expression levels are unaffected. Moreover, it was observed that an association
between NBS1 and E2F1 is increased in response to DNA damage, suggesting
that E2F1 may promote NBS1 foci formation through a direct or indirect
interaction at sites of DNA breaks. E2F1 deficient cells also display impaired foci
formation of RPA and Rad51, which suggests a defect in DNA end resection and
formation of single-stranded DNA at DNA double-strand breaks. I also found
E2F1 status affects foci formation of the histone acetyltransferase GCN5 in
response to DNA double-strand breaks. E2F1 is phosphorylated at serine 31
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(serine 29 in mouse) by the ATM kinase as part of the DNA damage response.
To investigate the importance of this event, our lab developed an E2F1 serine 29
mutant mouse model. I find that E2F1 serine 29 mutant cells show loss of E2F1
foci formation in response to DNA double-strand breaks. Furthermore, DNA
repair and NBS1 foci formation are impaired in E2f1S29A/S29A cells. Taken
together, my results indicate novel roles for E2F1 in the DNA damage response,
which may directly promote DNA repair and genome maintenance.
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Chapter 1. Background and Introduction
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1.1 E2F family and E2F1
1.1.1 E2F family
The E2F transcription factor family is composed of eight E2F members
and three related differentiation regulated transcription factor proteins (DP),
which regulate the expression of genes involved in different process such as cell
proliferation, cell cycle progression, DNA replication, DNA repair and apoptosis
(1-5). All E2F members contain a DNA binding domain that binds to the promoter
of its target genes (Figure 1.1). E2F1-5 also have transactivation domains
located at the carboxyl terminus. E2Fs require these two domains as essential
structural components for their transcriptional regulatory function. Within the
transactivation domain there is a region involved in pocket protein (RB, p107 and
p130) binding, which regulates transcriptional activity and in turn cell proliferation.
Each E2F member has individual as well as overlapping functions. E2F1-3 are
thought to function primarily as the “activating” E2Fs. In contrast, E2F4 and 5 are
reported to possess transcriptionally repressive activity (6, 7). Furthermore,
E2F6, E2F7 and E2F8 are also considered as transcription repressors in an RB
family-independent manner (7).
DP proteins bind to several E2F members through their dimerization domain
to form functional E2F-DP heterodimers. The marked box domain which is
embedded between the transactivation domain and dimerization domain is
involved in multiple protein-protein interactions and is important for the apoptosis
induction function of E2F1 (8) (Figure 1.2).
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The role of the E2Fs in regulating the cell cycle has been well investigated (9,
10). When a cell is quiescent, E2F family members bind with pocket proteins to
form complexes that repress the transcription of cell cycle and cell proliferation
genes. Co-factors, such as DNMTs, HDACs, and SWI/SNF complexes, are
recruited to E2F target gene promoters by pocket proteins to alter chromatin
structure and inhibit access to the basal transcriptional machinery (11). Following
mitogenic stimulation by growth factors, cyclin D is expressed and associates
with cyclin-dependent kinase (CDK) 4/6 to form an activated complex that
phosphorylates RB family proteins. E2F transcription factors are released from
RB/E2F complexes when RB is hyperphosphorylated and in turn E2F
transcription factors are free to activate the expression of target genes for
proliferation, cell cycle progression, apoptosis induction, DNA replication and
repair. Among those E2F target genes, the major cell cycle regulators cyclin E
and A also facilitate cell cycle progression and G1/S phase transition by further
promoting phosphorylation of RB family proteins and other key cell cycle
regulators (6, 7).
1.1.2 E2F1 induces apoptosis
Among the E2F family members, E2F1 is special not only because it was the
first E2F family member to be identified but also it has a unique apoptosis
induction function in the presence of cell stress or when over-expressed (12-16).
Although recent research has reported that E2F3 can also function in the process
of apoptosis induction it may still mainly depend on the presence of E2F1 (1719).
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The mechanisms of apoptosis regulation by E2F1 are still not well
understood. In general, E2F1 induces apoptosis in either a p53 dependent (15,
16, 20, 21) or independent manner (22-25). It was shown that the p53 protein is
stabilized when E2F1 is over-expressed and this leads the cell to undergo
apoptosis. One mechanism by which E2F1 can induce p53 is through the
transcriptional regulation of the alternative reading frame protein (ARF), which is
a p53 activator, by repressing p53 ubiquitination and degradation via MDM2 (2628). Furthermore, it was also found that over-expression of E2F1 can activate the
PI3 kinase family member Ataxia-telangiectasia mutated (ATM), which is a main
regulator of the DNA damage response (DDR). Activation of ATM will induce
phosphorylation of its many downstream targets to regulate college processes,
such as DNA repair, cell cycle checkpoints, cell senescence and cell death. The
p53 tumor suppressor is one of most important targets of ATM and it is
phosphorylated at serine 15, which leads to further modifications, p53
stabilization and activation of p53 transcriptional capacity (29-31).
In cells lacking p53 or with mutant p53, E2F1 can still induce apoptosis
through p53-independent mechanisms, especially apoptosis induced in response
to DNA damage. E2F1 can transcriptionally promote expression of the p73
protein to induce apoptosis (22, 25). Recent research also showed that E2F1
uses the death receptor pathway to suppress cell survival (32). Other targets of
E2F1 that can induce apoptosis include Apaf1 and Caspase 3 (23).
1.1.3 Dual role of E2F1 in cancer development
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Research based on E2F1 null mice and a transgenic mouse model in which
E2F1 is over-expressed in epithelial tissue via a keratin 5 (K5) promoter
demonstrates that E2F1 displays paradoxical dual activities as both an oncogene
and a tumor suppressor in different experimental contexts (33-36). Spontaneous
tumors arise primarily in the skin epithelial tissue of K5 E2F1 mice and tumors
develop earlier when on a p53-deficient background (20, 36). These results
confirm an oncogenic role of E2F1 in vivo as suggested by earlier in vitro studies
(37, 38). Findings based on other E2F1 transgenic models also confirm the
oncogenic activity of E2F1 (39-41). Conversely, the same K5 E2F1 transgenic
mouse model is resistant to skin tumor development when used in the two-stage
(DMBA/TPA) carcinogenesis assay (36). In this assay, Ras mutation is the
initiating event to produce skin tumors and it was found that E2F1 overexpression inhibited carcinogenesis at the promotion stage, which required
functional p53 and ARF proteins (42).
Aside from the above observations, the earliest evidence for a tumor
suppressive function of E2F1 were found using an E2f1 knockout mouse model
(43, 44). T cells of mice lacking E2F1 have a moderate defect in their
development, but cells without E2F1 still display regular cell cycle kinetics. The
normal cell cycle progression in cells lacking E2F1 is possibly related to
compensation by other E2F family factors (45). Nevertheless, E2F1 null mice
develop spontaneous tumors. Dysplasia and tumors such as lymphomas and
reproductive tract sarcomas were found in these mice as they aged (43, 44). In
addition, a study from our laboratory using a Myc transgenic mouse model
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demonstrated that loss of E2F1 can accelerate the development of Myc-induced
epithelial tumors (46).
While the mechanism by which E2F1 functions as a tumor suppressor is not
very clear, there are several possible explanations that could help us understand
its role in tumor suppression. E2F1 can be considered as a transcriptional
repressor when it is bound with RB, with the RB-E2F1 complex turning off the
expression of genes important for proliferation. Based on this model, loss of
E2F1 would have the same effects as loss of RB.

However, there is no

significant evidence to support this model and it is now clear that other E2F
family members have the primary function of transcriptional repression (47).
It is natural to connect apoptosis induction function of E2F1 to its tumor
suppression ability. As discussed previously, E2F1 is a pro-apoptosis factor and
this function could inhibit tumor development under the stress of oncogenes. It is
also reported that apoptosis induced by Retinoblastoma (RB) protein inactivation
requires both E2F1 and p53 in some tissues. However, in Rb knockout mice,
tumor development was impaired or not affected by the absence E2F1 (12, 35).
Based on this result, E2F1 does not seem to act as a tumor suppressor in
response to RB deficiency. On the other hand, E2F1 appears to suppress tumor
development when Myc is over expressed in certain tissues. It is interesting that
decreased levels of apoptosis were not observed in this model but in fact
increased levels of apoptosis were found in Myc transgenic tissues lacking E2F1.
Taken together, these findings strongly suggest that E2F1 suppresses tumor
development through a non-apoptosis mechanism.
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Figure 1.1 E2F family
binding domain is indicated by yellow box and it only exists
exist in
The cyclin A-binding
E2F1-3b. The DNA-binding
binding domain is indicated by red color box and the DP
protein dimerization domain is indicated by pink box. Marked box domain,
domain which
is next to the dimerization domain, is indicated by purple color. The
transactivation domain is contain
contained in the C-terminus and the RB family proteinbinding motif is indicated
ted by blue color. DP proteins are binding partners of E2Fs,
containing a related dimerization domain and DNA binding domain. E2F7 and 8
do not require dimerization with DP proteins and have two DNA binding domains.
domains
Reproduced from (DeGregori,
DeGregori, J., and D.G. Johnson. 2006. Current
nt molecular
medicine 6: 739-748), with permission from Bentham Science Publishers Ltd.
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Figure 1.2 Subgroups of E2Fs and their functions.
Based on their biological activities, binding partners and co-factors, the E2F
family can separated into at least four subgroups. Among them, only E2F1-3
binds to RB, while E2F4 and 5 also bind to p107 and p130. E2F1-3 mainly
activate downstream target genes for proliferation and apoptosis when E2F-RB
interactions are dissociated. On the other hand, E2F4-5 are thought to function
primarily as transcriptional repressors and be important in the process of
differentiation. E2F6 acts as a transcriptional repressor independent of the RB
family and functions in organ differentiation and development. The interactions
and functions of E2F7 and E2F8 have not been well explored but it is suggested
that E2F7/8 also repress transcription and respond to DNA damage.
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Figure 1.3 Working model for E2F1 in reg
regulating cell cycle progression.
progression
In quiescent cells, E2F1 is bound to and repressed by RB with recruitment of
co-repressors (HDAC, etc). Follow mitotic stimulation by growth factors, elevated
elev
cyclin
yclin D levels promote phos
phosphorylation of RB by forming active cyclinD/CDK4
cyclinD/
or
6 complexes.. Consequently, the RB-E2F1 complex is dissociated and now free
E2F1 activates expression of its target genes. Those target genes encode
proteins involved in DNA replication and cell cycle progression.
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Figure 1.4 Working model for E2F1 regulation of apoptosis.
E2F1 can mediate apoptosis through both p53 dependent and independent
mechanisms.
A. E2F1 signaling to p53 through ARF, a gene that is transcriptionally
activated by E2F1, stabilizes p53 by repressing MDM2. E2F1 can also
induce phosphorylation of p53 at serine 15 by activating the ATM kinase
and in this way, trigger and activate p53.
B. For E2F1-induced, p53-independent apoptosis, E2F1 can transcriptionally
induce pro-apoptotic genes including APAF1, p73 and some caspases.
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1.2. Background on the DNA damage response
1.2.1 General background of DNA damage response
Each cell of the human body is confronted with around 104-105 DNA lesions
per day (48). This DNA damage needs to be repaired in a timely and efficiently
manner to maintain genomic stability. If not repaired, the accumulation of DNA
damage will block gene transcription and DNA replication and lead to mutations
that can cause cancer and other life threatening diseases.
Generally speaking, DNA is attacked by two different sources of harmful
agents: endogenous agents generated during metabolism and exogenous agents
from the environment. Ultraviolet (UV) light is one of the most common
environmental DNA damaging agents. UV-induced DNA damage is mainly
composed of cyclobutane pyrimidine dimers (CPD) and pyrimidine-pyrimidone
adducts (6-4 PP), which produce stalled DNA replication forks and DNA strand
distortion. Another prototypical DNA damaging agent is ionizing radiation that can
generate various forms of DNA lesions, with double-strand break as the most
toxic type. There are also numerous genotoxic chemicals, such as alkalyating
agents, that can cause several types of DNA damage (49).
To deal with these DNA lesions, an elaborate network of DNA damage
response systems is initiated. These include various DNA repair mechanisms
depending on the different types of DNA damage, damage tolerance processes
and cell cycle checkpoint pathways. The DNA damage response has important
functions and defects in DNA damage response factors can cause severe
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diseases, including neurological degeneration, premature aging, immune
deficiency and cancer susceptibility (50, 51).
1.2.2 ATM/ATR mediated DNA damage response pathways
The DNA damage response is a signal transduction network that senses and
responds to DNA damage to protect the cell and organism. This network consists
of sensors, transducers and effectors (Figure 1.5). The key signal transducers of
DNA damage response signaling are several members of the PI3 kinase family:
ATM kinase and Ataxia-telangiectasia and Rad3 related (ATR) kinase (52-54).
ATM is activated in response to DNA double-strand breaks and ATR is activated
in response to stalled replication and transcription forks. ATM/ATR target two
well studied downstream protein kinases that execute functions of the DNA
damage response: Chk1 and Chk2. Chk1 and Chk2 reduce CDK activity through
various mechanisms such as activation of p53 and induction of the cyclindependent kinase inhibitor p21 (53, 55, 56). Inactive CDK slows down or stops
cell cycle progression at different cell cycle checkpoints (G1-S, intra-S and G2M). This arrest of the cell cycle gives the cell more time for DNA repair before the
cell progresses to DNA replication or mitosis. In general, ATM/ATR improves
DNA repair by several mechanisms: by activating transcription factors to induce
the expression of DNA repair proteins, by modifying chromatin structure to
facilitate the recruitment of DNA repair factors to damage sites, and by regulating
the activity of DNA repair proteins by direct phosphorylation or indirectly through
ubiquitylation, acetylation or SUMOylation (57). After the above events, if there is
effective DNA repair, the DNA damage response will be inactivated to allow the
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cell to resume its normal function. If the damage is too severe, chronic DNA
damage response signaling can trigger cell death by apoptosis or senescence,
both of which can have potential antitumor functions (58, 59).
It is well known that ATM is activated in response to DNA double-strand
break but the mechanism of ATM initiation is not yet very clear. Recent research
has shown that ATM is recruited to broken DNA molecules by a DNA double
strand break sensor, the Mre11-Rad50-Nbs1 (MRN) complex. Usually, ATM
exists as inactive homodimers but when ATM is recruited to a DNA double-strand
break site, it autophosphorylates itself on multiple residues and the dimers
dissociate into active monomers. The MRN complex itself is one of the
substrates of ATM and is also important for downstream signaling by recruiting
other substrates to ATM and DNA double-strand break sites. Beside the MRN
complex, there are many other mediators, such as 53BP1 and BRCA1 that are
also ATM kinase substrates that play various roles in recruiting additional
substrates and checkpoint signaling. At the site of DNA damage, the variant
histone H2AX is phosphorylated on serine 139 by ATM/ATR and it is referred to
as γH2AX (60). Mediator of DNA damage checkpoint protein 1 (MDC1) is
recruited directly to γH2AX through a phospho-specific interaction and MDC1 in
turn recruits many additional factors to DNA damage sites (61). The
accumulation of these factors at sites of DNA damage leads to the formation of
IR-induced foci (IRIF). MDC1 binds to Nijmegen breakage syndrome 1 (NBS1)
through another phospho-specific interaction to recruit the MRN complex (62).
Although the MRN complex can directly bind broken DNA ends, the majority of
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MRN is recruited by γH2AX-MDC1, resulting in microscopically visible foci
(Figure1.5). H2A ubiquitination at DNA double-strand break is also dependent on
γH2AX and MDC1 and involves yet another phosphorylation-dependent
interaction between MDC1 and the RNF8 E3 ubiquitin ligase. RNF8-mediated
ubiquitination of H2A in turn recruits another E3 ligase, RNF168, which further
amplifies the ubiquitin signal (63). RNF168 is important for the recruitment of
BRCA1 through the ubiquitin-binding protein Rap80 and ABRA1 (64-66). 53BP1,
an important mediator in DNA recombination and Chk2 activation, is also
recruited to IRIFs in an MDC1-H2AX dependent manner. The role of IRIF in DNA
damage response signal transduction and DNA damage repair is not yet well
understood. The manner of recruitment of mediator proteins in the DNA damage
response will be an active area of future study.
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Figure 1.5 ATM signaling pathway
In response to DNA double-strand breaks, inactive ATM dimer is
autophosphorylated at serine 1981, as well as other sites, and becomes
an active monomer. The active ATM kinase phosphorylates hundreds of
down targets to regulate a variety of important cell process, such as DNA
repair, induction of checkpoints and apoptosis. A brief description can be
found in the Chapter 1. Reproduced from (Kurz, E. U., and S. P. LeesMiller. 2004. DNA repair 3:889-900), with permission from Elsevier Ltd.
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1.2.3 Genomic instability and endogenous DNA damage
It has been estimated that up to 105 spontaneous DNA lesions per cell per
day are generated by normal cellular metabolism (51). Some endogenous DNA
damage arises during physiological processes such as occasional base
mismatch during replication or DNA strand break due to faulty topoisomerase
activity. In addition, non-enzymatic methylations and hydrolytic reactions produce
thousands of DNA base lesions in the cell each day. Furthermore, oxidized DNA
base and DNA break are generated by another endogenous source of DNA
damage: reactive oxygen species (ROS), which is derived from normal cellular
metabolism. These reactive oxygen and nitrogen compounds could also be
generated by macrophages and neutrophils at sites of infections and
inflammation (67). Such endogenous source chemicals could attack DNA and
lead to adducts that impair DNA base pairing, block DNA replication and
transcription, cause base deletion or single-strand break (SSB). DNA doublestrand break can be formed when two SSBs are generated in close proximity or
when the DNA replication apparatus meet a SSB or some other lesions (49). To
maintain genomic integrity, DNA damage must be repaired effectively. A defect in
DNA damage response factors can lead to accumulations of various type of DNA
damage and lead to various diseases, such as cancer.
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1.2.4 Double-strand break repair
Although DNA double-strand break do not occur as frequently as some other
types of DNA damage, they are quite toxic and difficult to repair. DNA doublestrand break repair is performed by two principal repair mechanisms:
nonhomologous end joining (NHEJ) and homologous recombination (HR).
Besides these, alternative-NHEJ and single-strand annealing (SSA) are other
repair pathways.
In mammals, NHEJ is the predominant DNA double-strand break repair
pathway and functions in all phases of the cell cycle. In NHEJ, the initiating step
is binding of a heterodimer of Ku protein to a double-stranded DNA end. This
step senses the DNA double-strand break by Ku protein which then interacts with
the protein kinase DNA-PK resulting in assembly of the DNA-PK complex and
activation of its kinase activity. DNA-PK activates and recruits essential repair
factors such as end-processing enzymes, polymerases and DNA ligase IV to
load to DNA break sites to facilitate repair. Classic NHEJ requires limited DNA
end resection and almost always results in sequence deletions, so it is an errorprone repair mechanism (68).
Homologous recombination repair uses sister-chromatid sequences as the
template to perform faithful repair. It only occurs in S and G2 phase and it is an
error free repair mechanism. The initiating step of homologous recombination
repair is strand resection and coating with the replication protein A (RPA)
complex. The RAD51 protein is then recruited and loaded onto single-stranded
DNA with the assistance of BRCA2 protein (69). Following this step, strand
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invasion creates a D-loop and a Holiday junction. Finally, strand extension is
performed through DNA synthesis using the sister chromatid as a template.
Holiday junction resolution terminates the homologous recombination repair
process. According to the cell cycle phase and the nature of the DNA doublestrand break, different subpathways of homologous recombination repair exist
(70) (Figure 1.6).
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Figure 1.6 An overview of DNA double-strand break repair pathway
responding to IR damage
In response to DNA double
double-strand breaks, Mre11-Rad50-Nbs1
Nbs1 (MRN)
complex senses the DNA damage and recruits ATM to the site of DNA
damage. The activated ATM further phosphorylates NBS1 and other
substrates factors to amplify the DNA damage signaling transduction and
facility DNA repair. Homologous recombination repair and NHEJ represent
two important DNA double
double-strand break repair pathways.
pathway
Brief
descriptions can be ffound in Chapter 1. Reproduced from (Lobrich
Lobrich M., and
P.A. Jeggo. 2007. Nature reviews 7:861-869.),
), with permission from
Nature publishing group
group.
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1.3 DNA damage repair and chromatin modifications
In eukaryotic cells, DNA is packaged into a compact chromatin structure that
is mainly constructed with histones. The nucleosomes are formed by core
histones including two H2A-H2B dimers and a H3-H4 tetramer, which are
connected by the linker histone H1. The length of DNA strand wrapping around
this structure is about 146 base pairs. The structure is then condensed into a
higher order structure, which is a fiber around 30 nm in diameter, and then this
fiber is further condensed into chromatin which is visible with conventional
microscopes (71). At the same time, the maintenance of chromatin structure
requires some non-histone proteins, including DNA polymerase, scaffold protein,
heterochromatin protein 1 and polycomb, which can serve as chaperons or
scaffolds (72).
Chromatin structure plays an important role in all biological processes
involving DNA, such as mitosis, meiosis, DNA damage response, gene
expression and DNA replication. Chromatin provides reliable protection and a
more stable environment for DNA and the chromatin structure changes lead to
delicate regulation of DNA activities. Chromatin structure functions as a barrier to
processes involving DNA, such as DNA replication and transcription, and
appropriate chromatin modification machinery is necessary for further pursuit of
these activities.
This principle also works in the process of DNA repair. It is reported that
chromatin structure inhibits DNA repair both in vitro and in vivo (73, 74). After
DNA damage, the damaged site first needs to be recognized and sensed by
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specific proteins, but their accessibility is prevented by the chromatin structure at
the sites of damage (75, 76). To facilitate DNA repair, histone modifications and
chromatin remodeling are executed at the damaged area. These processes
include acetylation and methylation, as well as phosphorylation, ubiquitylation
and ribosylation,
In response to DNA double-strand breaks, the earliest event of histone
modification is phosphorylation of the histone variant H2AX, called γH2AX. It
appears quickly soon after damage occurs and distributes out up to 50kb flaking
the damaged site (77). γH2AX provides a docking site for MDC1 via BRCT
domains in MDC1, which mediates many of the downstream pathways for
checkpoint induction and DNA double-strand break repair. MDC1 is also be
phosphorylated by Casein kinase 2 (CK2) and this event promotes the interaction
of MDC1 with NBS1 protein through the FHA domain of NBS1. NBS1 is a
component of the Mre11-Rad50-NBS1 (MRN) complex and functions to recruit
ATM to sites of DNA double-strand break. Activated ATM phosphorylates H2AX
to amplify the DNA damage response signal. These events promote transduction
of the ATM-mediated DNA damage response signal to diverse downstream
proteins,

which

are

essential

for

DNA

repair,

apoptosis,

checkpoint

establishment, and senescence induction (78-80).
Following γH2AX formation, further chromatin modifications also occur in
response to DNA double-strand breaks. MDC1 also recruits RNF8 protein by a
phospho-specific binding site.

RNF8 is a specific E3 ubiquitin ligase in

conjunction with the UBC13 E2 conjugating enzyme to add mono- or poly-
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ubiquitin to H2A and H2AX at sites of DNA double-strand break (64). Then
another E3 ligase RNF168 further amplifies the ubiquitylation signal, to produce
more ubiquitylated H2A (uH2A) to increase the recruitment of downstream DNA
repair factors. Formation of uH2A at sites of DNA double-strand break promotes
dimethylation of histone H4 at lysine 20, although the mechanism is not known.
This event supplies a binding site for 53BP1 protein, which plays an important
role in DNA double-strand break repair and checkpoint induction (81-85). The
BRCA1 localization to sites of DNA double-strand break is also essential for DNA
double-strand break repair and checkpoint induction (86-89). In this process,
some other chromatin modifications also coordinate with ubiquitylation to recruit
downstream repair proteins. For example, a histone acetyltransferase (HAT),
TIP60, can acetylate H2A and other core histones at sites of DNA double-strand
break to facility recruitment of DNA damage response proteins (90-95) (Figure
1.7).
Beside these, chromatin remodeling plays an important role in the DNA
damage response and needs specific ATP-dependent chromatin remodeling
complexes. Among chromatin remodeler families, a SWI/SNF family member
Ino80 is well known to be involved in the DNA double-strand break response (96,
97). All these events link chromatin modifications and remodeling with repair of
DNA double-strand break (98-100).
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Figure 1.7 DNA repair in the context of chromatin modification.
When a DNA double-strand break happens in chromatin, γH2AX is formed at
the sites of DNA lesions, and this event leads to the recruitment of MDC1. MDC1
recruits the MRN complex and ATM to amplify the DNA damage response signal.
At the same time, Tip60 HAT acetylates γH2AX and recruits E2 ubiquitinconjugating enzyme UBC13, which adds ubiquitin to H2A and γH2AX. This
modified γH2AX will be removed from chromatin surrounding broken ends of
DNA double-strand break. Furthermore, ATM- phosphorylated MDC1 can attract
the RNF8 E3 ubiquitin ligase-UBC13 complex to promote ubiquitylation of H2A
and γH2AX. These events cause subsequent binding of RNF168, which is
another E3 ubiquitin ligase, to the polyubiquitylated histones resulting in the
amplification of the ubiquitylation cascade. These histone modifications promote
recruitment of 53BP1 through recognition of dimethylated H4 at lysine 20, and
Rap80-ABRA1-BRCA1 complex, through recognition of polyubiquitin. These
downstream events can directly play a role in checkpoint induction and DNA
repair. Reproduced from (Van Attikum, H., and S.M. Gasser. 2009. Trends in
cell biology 19:207-217.), with permission from Elsevier Ltd.
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1.4 E2F1 plays a role in the DNA damage response
A number of E2F family members are now known to respond to DNA
damage. E2F1 is the first reported and the best characterized E2F family
member shown to respond to DNA damage.

E2F1 protein is stabilized and

accumulates in response to various forms of DNA damage through an increase
in its half-life (101, 102). This involves phosphorylation by ATM or ATR at amino
acid serine 31, which is a unique site for E2F1 not found in other E2F family
members (103). This phosphorylation event creates a binding site for 14-3-3τ
and interaction between E2F1 and 14-3-3τ prevents E2F1 ubiquitination and
degradation (104). Besides ATM and ATR, it was reported that the Chk2 kinase
can also phosphorylate human E2F1 at another site (not conserved in mouse
E2F1) and this phosphorylation event also contributes to stabilization of E2F1,
although the mechanism is unclear (105).
It was assumed that E2F1 stabilization in response to DNA damage would
transcriptionally activate pro-apoptotic targets to induce cell death. Indeed, in
some contexts apoptosis in response to DNA damage does involve E2F1 and the
transcriptional induction of the p73 gene (103, 104, 106). Specific targeting of
E2F1 to the p73 promoter in response to DNA damage involves the acetylation of
E2F1 at multiple residues near its DNA-binding domain, which is stimulated by
serine 31 phosphorylation (73). It is reported that E2F1 acetylation occurs only in
response to DNA double-strand breaks but not in response to UV irradiation. The
enzyme that acetylates E2F1 in response to DNA double-strand breaks is still
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unclear

with

different

groups

proposing

that

either

P/CAF

or

p300

acetyltransferases are responsible for this modification of E2F1 (106, 107).
DNA damage also increases the interaction between E2F1 and the RB tumor
suppressor protein and this leads to the transcriptional repression of many cellcycle-related genes such as cyclin A (108, 109).

Surprisingly, an E2F1-RB

complex may also contribute to the transcriptional activation of pro-apoptotic
genes like p73 and caspase 7 (108). However, there are other reports that
indicate RB is released from E2F1 in response to DNA damage (110, 111). In
fact, an E2F1 transcriptional repression complex not containing RB but
containing TopBP1 was demonstrated to form following DNA damage (112, 113).
It was previously reported that TopBP1 interacts with RAD9 and could activate
ATR at sites of DNA damage (114-116). TopBP1 contains nine BRCA1 Cterminal (BRCT) domains and the sixth BRCT domain specifically binds E2F1
when phosphorylated on serine 31 (113).
TopBP1 specifically represses the transcriptional activity of E2F1, but not
other E2F family members, following E2F1 phosphorylation by ATM/ATR (112).
Following DNA damage, regulation of E2F1 by TopBP1 is important for inhibiting
cell cycle progression, repressing apoptosis and promoting cell survival (113). It
is reported the PI3K/AKT kinase can phosphorylate TopBP1 at serine 1159,
which creates a binding site for a BRCT domain in another TopBP1 molecule
(112). So AKT regulates the formation of homodimer of TopBP1, which is
required to bind E2F1. Thus, AKT activity determines whether TopBP1 will inhibit
E2F1-dependent transcription of cell cycle and pro-apoptotic genes in response
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to DNA damage or whether E2F1 stabilization will activate the expression of
these genes to induce apoptosis. This model is consistent with Nevin’s report
that identified a subset of E2F1 target genes that is specifically repressed by
PI3K/AKT signaling (117). This signaling may allow TopBP1 to integrate both
survival and DNA damage response signals to modulate cell fate through E2F1
regulation.
TopBP1 binding not only inhibits E2F1 transcriptional activity, but also
localizes E2F1 to sites of DNA double-strand break (112). A discussed in the
next section, findings from our lab suggest that E2F1 has a direct function in
promoting repair of UV radiation-induced DNA damage (118). Furthermore, E2F1
was shown to associate with the MRN complex through the N terminus of NBS1
(119). Taken together, evidence suggests that E2F1 could play a direct role in
promoting the repair of DNA double-strand break and maintaining genome
stability.
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1.5 E2F1 plays a role in UV induced DNA damage.
In previous studies, I have shown that loss of E2F1 leads to significantly
delayed UV damage repair both in vitro and in vivo (120). To elucidate the
mechanism, I irradiated the cells with filtered UV light through small pores that
creates localized DNA damage to areas of 3 µm to 8 µm in diameter in the
nuclei. I then stained the cells with specific antibodies against CPD or 6-4PP
photoproducts to visualize the local UV damage by immunofluorescence. By costaining with antibody against E2F1, I observed clear co-localization of E2F1 with
UV damage, which requires its serine 31 site and the ATR kinase. In addition, I
demonstrated that knockdown of E2F1 with RNA interference does not affect the
expression levels of UV damage repair proteins, including XPA, XPC, DDB1,
DDB2, p62 of TFIIH complex, XPF and RPA2. However, E2F1 knockdown does
cause significantly decreased recruitment of XPA, XPC and p62 proteins to sites
of UV damage, which can well explain the impaired DNA repair in the absence of
E2F1. These findings indicate that E2F1 impacts UV damage repair by affecting
DNA repair protein accessibility in a transcription-independent manner. Further
mutation analysis also confirmed that serine 31 and the dimerization domain, but
not the DNA binding domain or transactivation domain, which is essential for
transcription, are required for localization of E2F1 to UV damage sites and
subsequent efficient DNA repair. It was interesting to observe that the Marked
box domain of E2F1 is not required for its recruitment, but indispensible for its
functions in DNA repair. Because this domain is responsible for protein-protein
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interactions, further investigations focused on this domain will be of great help in
understanding the function of E2F1 in DNA repair (118).
Following the above study, I further dissected the mechanisms by which
E2F1 affects repair protein accessibility. Among all possibilities, it is likely that
E2F1 affects chromatin accessibility of the repair machinery. Chromatin structure
functions as a barrier for the recruitment of DNA repair proteins to damaged DNA
areas, while E2F1 is intrinsically able to bind to chromatin modifiers as
demonstrated by its functions as a transcription factor under other settings, such
as cell cycle regulation. In my study I found that E2F1 binds to the GCN5 histone
acetyltransferase and brings GCN5 to sites of UV damage, without affecting the
level of GCN5. Because GCN5 mostly uses histone H3 and H4 as substrates, I
examined a battery of acetylated H3 and H4 sites using specific antibodies and
found that acetylated H3 at lysine 9 (H3K9Ac) and acetylated H4 at lysine 16
(H4K16Ac) increase at sites of DNA damage. After I knocked down either E2F1
or GCN5, both the total level and the localization of H3K9Ac, but not H4K16Ac,
were significantly impaired. These findings indicate that E2F1 uses GCN5 to
induce local histone H3 acetylation at lysine 9, which probably contributes to
changes in the local structure of the chromatin and facilitates recruitment of DNA
repair proteins. To confirm this hypothesis, I also knocked down GCN5 with RNA
interference assay and demonstrated that localization of XPA, XPC and p62 to
sites of DNA damage is also significantly diminished. Our DNA repair assays
also showed that UV damage repair is significantly impaired by the knockdown of
GCN5, similar to E2F1. It should be pointed out that H4K16Ac also appears to be
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a specific histone modification to UV damage, but apparently it is not regulated
by E2F1 or GCN5 (121).
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1.6 Hypothesis
Both endogenous and exogenous agents constantly damage cellular DNA
constantly. Accumulation of DNA damage causes genomic mutations and even
cancer development. In contrast, DNA damage is also capable of inducing cell
death, which makes many DNA damaging agents potent cancer therapeutic
modalities, such as ionizing irradiation and some DNA double-strand break
inducing drugs. Thus, it is essential to study the cellular response to DNA
damage to further investigate cancer development mechanisms and the
molecular biology related to cancer therapy. ATM and ATR kinases are the two
key players in various DNA damage response pathways and their functions and
downstream targets have been well investigated (122).
E2F1 is the first indentified member in the E2F family and regulates the
expression of multiple genes critical for cell cycle progression, apoptosis, DNA
replication and DNA repair (1-5). It was found that E2F1 is phosphorylated by
ATM/ATR at serine 31, which is unique for E2F1 in the E2F family. The
phosphorylation of serine 31 is required for E2F1 protein stabilization in response
to DNA damage and creates a binding site for the sixth BRCT domain of
TopBP1. The transcriptional activity of E2F1 is repressed by interaction with
TopBP1 independent of RB. Furthermore, TopBP1 also localizes E2F1 to sites of
DNA double-strand break, although the function of E2F1 at sites of break
remains unclear (101-104, 112).
It was reported by our group that E2F1 functions to facilitate repair of UV
induced DNA damage through a non-transcriptional mechanism involving
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enhanced recruitment of DNA repair enzymes to sites of damage (118, 120,
121). For this project, I hypothesize that E2F1 has important transcriptionindependent functions for the recruitment and/or retention of some DNA
repair factors to sites of double-strand break.

32

Chapter 2.

Absence of E2F1 causes accumulation of spontaneous DNA

damage and genomic instability
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2.1 Introduction
The development of cancer significantly relies on the acquisition of genomic
instability, which is created by defective surveillance and repair mechanisms for
DNA damage caused by endogenous and exogenous sources (123). Newly
developed concepts in cancer biology have emphasized the importance of
genomic instability in the establishment of cancer hallmarks, and add it in the
category of “Enabling Characteristics” (124). With the advance of technologies
and knowledge, it has been realized that genetic alterations are truly
indispensible for tumorigenesis and function as the predominant determining
factor. When genomic instability creates growth or survival advantages, cells with
this abnormality are frequently selectively expanded. This process can serve as
the starting point of carcinogenesis. Genomic instability can also influence
subsequent steps during carcinogenesis such as invasion and metastasis.
The significance of genome stability maintenance and DNA damage
response mechanisms cannot be over-emphasized. In fact, numerous important
tumor suppressors are themselves critical DNA repair factors or DNA damage
response regulators with p53, BRCA1, and ATM as prototypical examples (48).
Loss of these factors in cells leads to genomic instability followed by tumor
development. There are also various pathway-specific DNA repair factors whose
loss or deficiency can cause specific forms of genomic instability and tissuespecific tumorigenesis. For example, defective XPC or XPA proteins in the
nucleotide excision pathway are strongly associated with UV radiation-specific
DNA damage, mutations and skin cancers.
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In addition to DNA repair factors, proteins that regulate orderly cell cycle
progression and death are also important in the maintenance of genomic stability
in a relatively indirect manner. Loss of these proteins can cause uncontrolled
DNA replication and its related complications. Over-replication of DNA inevitably
results in errors that may be beyond the capacity of DNA repair and genomic
instability is therefore initiated. For example, the RB protein is critical in cell cycle
regulation and loss of RB has been shown to be associated with dramatic
genomic abnormalities (125, 126).
The E2F family has been considered as the primary players in cell cycle
regulation downstream of RB. However, it is now realized that the E2F family
regulates an extremely wide diversity of biological processes beyond promoting
cell cycle progression. Among them, E2F1 was clearly shown to have dual roles
in tumor development depending on different circumstances. E2F1 is a potent
apoptosis inducer and can activate p53 and transcriptionally regulate a number
of pro-apoptotic genes. However, those functions failed to show a clear
correlation with a role for E2F1 in tumor suppression. In contrast, there are
accumulating data suggesting that E2F1 functions as an important chromatin
modifier to facilitate recruitment of nucleotide excision repair factors for UVinduced DNA damage in cell culture. Therefore, a role for E2F1 as a tumor
suppressor could largely depend on its functions in DNA repair.
In addition to UV-induced DNA damage, E2F1 also accumulates at sites of
DNA double-strand break, but whether and how E2F1 functions to promote DNA
double-strand break repair is at present unknown. Based on these findings, I
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hypothesized that E2F1 has transcription-independent functions for the
recruitment and/or retention of DNA repair factors to sites of double-strand break.
To test this hypothesis, I investigated whether the loss of E2F1 causes
genomic instability as demonstrated for other well-established tumor suppressors
with critical DNA repair functions, as well as examining if E2F1 plays an
important role in the response of DNA double-stranded breaks (127).
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2.2 Materials and methods
2.2.1 Cell culture
Primary mouse adult fibroblasts (MAFs) were isolated from E2f1 knockout
and wild type mice. Briefly, the peritoneal fascia of mice at least 5 weeks old was
excised, minced into small pieces, and dissociated by agitation in 0.2% mg/ml
collagenase supplemented with 100 units DNase I. After washing in PBS, tissue
was incubated in 25% trypsin for 20 minutes. Isolated cells are then washed
twice and plated in tissue culture dishes. MAFs were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum
(FBS). The HCT116 colon carcinoma cell line was obtained from ATCC and
cultured in McCoy’s 5A medium (Gibco) with 10% FBS.
2.2.2 DNA double-strand break treatments and agents
Neocarzinostatin (NCS) is a radiomimetic drug obtained from Sigma. During
treatment, normal 10% FBS DMEM medium was changed to 10% FBS DMEM
with NCS (50 ng/ml). At the appropriate time point, cells were fixed for
immunofluorescence experiments or harvested for Western blot.
For ionizing radiation (IR) cells were cultured in 10 cm plates or 4 well
chamber slides and treated with the indicated Gy dose using a RS-2000
Biological Irradiator (Rad Source).
2.2.3 Immunofluorescence staining
Briefly, cells grown on chamber slides (Nunc.) were washed with PBS and
fixed using 3.7% formaldehyde. Fixed cells were incubated with 3% BSA for an
hour, washed twice with washing buffer (0.5% BSA in PBST or PBST), incubated
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with appropriate primary antibodies (e.g., specific for γH2AX or E2F1), and
followed by incubation with fluorescently tagged secondary antibody (Alexa 488
or Alexa 594, Invitrogen). Cells were then stained with DAPI to identify the
nucleus and sealed in mounting media (Vector Lab) with cover slips. Appropriate
fluorescent images were captured using a Nikon eclipse 80i microscope
equipped with an X-cite 120 fluorescence illumination system and Metamorph
image analyzed software. The foci numbers were analyzed and counted using
the Focicounter software program on randomly selected pictures captured for
each experimental group (128).
2.2.4 Cytogenetic analysis
Primary mouse keratinocytes isolated from 1-2 day old pups were treated
with colcemid for 2.5 hours and metaphase spreads counted. At least 40
metaphases were counted for each genotype. The values for each genotype
represent the average from 3 different mice.
2.2.5 Western blot analysis
E2f1 knockout or wild type MAFs were cultured on 10 cm plates in starvation
medium (0.5% FBS in DMEM) for 24 h then cultured in normal medium (10%
FBS in DMEM) for at least more than 24 h before treatment. Whole cell lysates
were harvested at different time points using 1X lysis buffer (Cell signaling).
Antibodies were obtained from the following sources: E2F1 (C-20), β-tubulin,
Santa Cruz; γH2AX, Millipore.
2.2.6 Comet assay
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The single cell gel electrophoresis or comet assay was performed using the
comet assay kit from Trevigen (17, 129, 130). Briefly, after different treatments
(IR or mock), cells are harvested and embedded in low melting agarose on a
glass slide and incubated overnight at 4oC in lysis buffer. After washing, samples
were electrophoresed at 19 V for 5-20 minutes in TBE and stained with SYBR
Green. Nuclei were visualized and images captured using a fluorescent
microscope. Tail length and Olive moment of at least 70 nuclei per slide were
calculated using COMETSCORE software (Tritek).
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2.3 Results
2.3.1 E2F1 accumulates at sites of NCS-induced DNA double-strand break
To confirm that E2F1 can form foci by accumulating at sites of DNA doublestrand break, I applied the radiomemitic drug neocarzinostatin (NCS) to HCT116
cells to induce double-strand break then used immunofluorescence (IF) to detect
E2F1 localization. Phosphorylation of the histone variant H2AX (referred to as
γH2AX), a widely used marker of DNA double-strand break, was used as a
positive control to detect co-localization of E2F1 with sites of DNA double-strand
break.
E2F1 staining in mock treated cells was relatively even throughout the
nucleus. In contrast, NCS treated cells showed increased staining intensity and
foci formation that partially co-localized with γH2AX foci (Figure 2.1). This
confirms a previous report that E2F1 accumulates at sites of DNA double-strand
break to form foci (112) and indicates potential direct involvement of E2F1 in the
repair of DNA double-strand breaks.
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Figure 2.1 E2F1 forms foci that partially co-localizes with γH2AX in
response to DNA damage.
HCT116 cells were mock treated or treated with neocarzinostatin (NCS
50ng/ml) for 15 min then incubated for an additional 1 h in fresh media.
Immunofluorescence was performed to examine co-localization of E2F1 with
γH2AX. Reproduced from (Chen,J, Cell Cycle 10:1287-1294.), with permission
from Landes Bioscience.
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2.3.2 E2F1 deficiency leads to genomic instability
Since E2F1 protein stability and subcellular localization are regulated in
response to DNA damage, we wonder whether the absence of E2F1 would affect
genome stability. A previous graduate student, Raju Pusapati performed
cytogenetic analysis on primary mouse keratinocytes lacking E2F1. This analysis
showed increased numbers of chromosomal breaks, fragments, and fusions in
cells lacking E2F1 compared to wild type cells. This result indicates that E2F1 is
involved in maintaining genomic integrity.
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Figure 2.2 Genomic instability in the absence of E2F1.
Primary mouse keratinocytes isolated from 1-2 day old pups were treated with
colcemid for 2.5 h and metaphase spreads counted. At least 40 metaphases
were counted for each genotype. The values for each genotype represent the
average from 3 different mice. Arrows indicate chromosomal breaks, fragments
and fusions (Experiment performed by Raju Pusapati).
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2.3.3 Absence of E2F1 leads to the accumulation of endogenous DNA
damage.
It is well known that γH2AX is a rapid and sensitive marker for DNA doublestrand break (131). Immunofluorescence (IF) staining for γH2AX foci was used to
estimate the amount of DNA damage in cells from E2f1 knockout and wild type
mice.

Untreated

primary

mouse

adult

fibroblasts

(MAFs)

were

immunofluorescently stained for γH2AX and fluorescent images were captured
randomly. γH2AX foci were counted using the image analysis software
Focicounter (128).
I observed that γH2AX foci numbers are increased in E2f1 knockout cells,
even in the absence of an exogenous DNA damaging agent. Only 35% of E2f1-/MAFs showed no visible γH2AX foci while 60% of wild type MAFs lacked visible
γH2AX foci. Furthermore, approximately 25% of primary E2f1-/- MAFs displayed
more than 6 γH2AX foci per cell while only 5% of wild type MAFs had 6 or more
foci (Figure 2.3). This result strongly suggests that cells lacking E2F1 display
significantly more spontaneous DNA damage, in particular DNA double-strand
breaks.
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Figure 2.3 The absence of E2F1 leads to spontaneous DNA damage.
A. Untreated primary wild type and E2f1 knockout MAFs were
immunofluorescently stained for γH2AX. DAPI was used as a counterstain.
B. Images were analyzed using the FociCounter software program. The
percentage of cells presenting different foci number was calculated after scoring
more than 85 cells for each genotype in three independent experiments.
*indicates statistically significant difference (p<0.05). Reproduced from (Chen,J,
Cell Cycle 10:1287-1294.), with permission from Landes Bioscience.
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2.3.4 E2F1 deficiency impairs recovery from IR
I found that E2F1 is also important for cells to recover from ionizing radiation
(IR) treatment. Western blot analysis for γH2AX was performed to indirectly
evaluate and monitor DNA damage production and recovery over time.
Consistent with our previous results, MAFs without E2F1 showed increased
levels of γH2AX even before IR treatment (Figure 2.4A). After IR treatment,
γH2AX was generated in both wild type and E2f1-/- MAFs but cells without E2F1
displayed higher levels of γH2AX compared to wild type MAFs. Moreover, while
γH2AX disappears in wild type cells at the 6h time point after irradiation, cells
lacking E2F1 showed persistent γH2AX after irradiation up to the 12 hours time
point.
The single cell gel electrophoresis assay (also referred to as comet assay) is
widely used to measure DNA breaks. A similar phenomenon was observed when
I used the comet assay to monitor DNA damage in wild type and E2f1-/- MAFs. In
harmony with the finding in the above western blot, primary MAFs lacking E2F1
showed significantly increased DNA damage, compared to wild type MAFs
without any treatment. The absence of E2F1 also results in anomalously higher
levels of DNA breaks at one hour and persistence of DNA damage at 24 hours
post-IR (Figure 2.4B) All in all, these findings suggest the absence of E2F1
causes increased levels of endogenous DNA damage and impaired repair of IR
induced DNA double-strand break.
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Figure 2.4 The absence of E2F1 impairs cell recovery following IR
exposure.
A. Primary wild type (lanes 1-6) and E2f1 knockout (lanes 7-12) MAFs were
untreated (Un, lanes 1 and 7) or treated with 5 Gy of IR and harvested at
different time points: Immediately (0h, lanes 2 and 8); 1 h (1h, lanes 3 and 9); 6 h
(6h, lanes 4 and 10); 12 h (12h, lanes 5 and 11); and 24 h (24h, lanes 6 and 12).
Western blot analysis was performed using antibody to γH2AX and β-tubulin.
Reproduced from (Chen,J, Cell Cycle 10:1287-1294.), with permission from
Landes Bioscience.
B. Primary wild type and E2f1 knockout MAFs were untreated or treated with 10
Gy of IR and incubated for 1 h and 24 h. Cells were harvested and subjected to
the comet assay. Images of nuclei and comet tails were taken and the Olive
moment of each tail was calculated using cometscore software. The average
Olive moment was determined for 50 cells per each genotype. *indicates
statistically significant difference (p<0.05). Reproduced from (Chen,J, Cell Cycle
10:1287-1294.), with permission from Landes Bioscience.

49

2.4 Discussion
It is well documented that E2F1 has dual roles in tumorigenesis and that E2f1
inactivation predisposes mice to spontaneous tumorigenesis. However, the
mechanisms underlying its functions in tumor suppression have not been clearly
elucidated. Our previously published data have clearly shown that E2F1 is critical
in UV-induced DNA damage repair (118, 120, 121). E2F1 may also be involved
in DNA double-strand break repair as it was shown that E2F1 localizes to DNA
double-strand break in a TopBP1- and ATM-dependent manner (113, 132). In
our current study, I confirm that endogenous E2F1 localizes to sites of DNA
double-strand breaks, indicating a direct function for E2F1 in double-strand break
repair.
A previous graduate student in our lab observed significantly increased
chromosomal aberrations in primary keratinocytes from E2f1 knockout mice,
including chromosomal breaks, fragments and fusions. To further test the validity
of the those findings, I also examined the presence of spontaneous DNA
damage, which is universally present in tumors with prominent genomic instability
(133).

I found that primary MAFs lacking E2F1 had significantly more DNA

damage foci as indicated by γH2AX staining. Consistently, the level of γH2AX
and numbers of foci in primary E2f1 knockout fibroblasts was significantly higher
than in wild type cells. Moreover, after treatment with IR, primary E2f1 knockout
fibroblasts showed a significantly delayed ability to resolve the DNA damage
compared to wild type cells as indicated by persistent γH2AX and comet tails.
This suggests an important role for E2F1 in DNA double-strand break repair.
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Overall, it appears that E2F1 plays a direct role in DNA double-strand break
repair and loss of E2F1 causes significant genomic instability. This role for E2F1
in maintaining genomic stability may be important for suppressing the cancerous
transformation of cells. Therefore, elucidation of the mechanisms underlying the
functions of E2F1 in the response to DNA double-strand breaks may shed light
on the mystery of E2F1 in tumor suppression.

51

Chapter 3.

E2F1 promotes the recruitment of DNA repair factors to DNA

double-strand break.
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3.1 Introduction
I have demonstrated that E2F1 is important for maintaining genomic stability,
which may reasonably explain its function in tumor suppression. However, the
mechanism by which E2F1 functions in DNA repair and genome maintenance is
at present unclear. In 2001 it was found that E2F1 is phosphorylated at serine 31
by the ATM/ATR kinases (103), which raises a question of role of E2F1 in the
DNA damage response. The same group demonstrated later that E2F1 binds to
TopBP1 when phosphorylated at serine 31 and recruits the Brg1/Brm containing
SWI/SNF chromatin remodeling complex to repress transcription. This TopBP1
mechanism of transcriptional repression is important for preventing E2F1induced cell cycle progression and apoptosis in response to DNA damage.
Previous results from our group also showed that E2F1 suppresses
apoptosis in response to UV-induced DNA damage as opposed to its traditionally
perceived role in apoptosis induction (120, 134). In addition, our group found that
E2F1 significantly contributes to the removal of UV-induced DNA damage,
especially during the early stages post-damage, which was demonstrated in vivo
in mouse skin and in vitro in cultured primary mouse fibroblasts (120). Further
study did not reveal any changes in nucleotide excision repair protein levels in
the absence of E2F1, indicating a transcription-independent mechanism for its
functions in DNA repair. More interestingly, further exploration revealed that
E2F1 recruits histone acetyltransferase GCN5 to modify the local chromatin
structure at sites of DNA damage, specifically promoting acetylation of histone
H3 at lysine 9. This modification may contribute an increase in accessibility of
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DNA repair proteins to sites of UV-induced DNA damage.
These findings inspired us to expand our understanding of functions of E2F1
in the DNA damage response by investigating role of E2F1 in repairing other
types of DNA damage. DNA double-strand breaks are the most detrimental type
of DNA damage and can arise due to both endogenous and exogenous
damaging sources. DNA double-strand breaks also serve as the prototypical
model in exploration of the DNA damage response network and our
understanding of ATM-mediated signaling pathways is largely derived from
studies of this type of DNA damage.
As mentioned previously, the DNA double-strand break response pathway is
composed of damage sensing, transduction and effectors proteins with
concurrent chromatin modifications to either promote the accessibility of the DNA
damage or to form a platform for signal amplification and transduction. There are
branches of error-free homologous recombination repair and error-prone
pathways, including non-homologous end joining. As for DNA double-strand
break repair, Mre11-Rad50-Nbs1 complex recruitment, ATM activation and foci
formation are the earliest and rate limiting steps. RPA foci formation with
recruitment of CtIP and ATR signaling factors is the point where DNA doublestrand breaks end resection occurs that marks the point for following the
homologous recombination pathway. In addition, recruitment of Rad51
recombinase would also be a critical event to examine in the absence of E2F1.
Chromatin modification has been recognized as an essential component
in the process of DNA double-strand break repair. Indeed, γH2AX foci formation
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is one of the earliest identified events signaling the presence of DNA damage
and is also critical for the amplification of the damage signal. The presence of
γH2AX provides a binding module for the MDC1 protein, which in turn recruits
NBS1, a component of the MRN complex. In addition, some reports have shown
that acetylation of histone H3 by Tip60 is important for ATM activation, while the
identification of histone ubiquitylation at sites of DNA breaks revealed a complex
cascade, sequentially performed by RNF8, RNF168, and perhaps other ubiquitin
ligases. It is now clear that ubiquitylated H2A and H2AX provide a key chromatin
context for DNA repair protein recruitment, with the best example being a BRCA1
containing complex (135). Other studies also suggested the involvement of
histone methylation in the process of DNA damage recognition and processing,
which needs further investigation (136, 137).
Interestingly, previous work from our group has demonstrated that E2F1 uses
the histone acetyltransferase GCN5 to facilitate nucleotide excision repair for UV
damage involving acetylation of histone H3 at lysine 9. Therefore I speculated
that E2F1 may use a similar mechanism to promote DNA double-strand break
repair. The potential relationship between E2F1 and the GCN5 complex,
including the TRRAP protein that was reported to interact with E2F1 in other
settings (138), will be specifically examined in the DNA double-strand break
response. In addition, other potential partners of E2F1 in chromatin modification
will also be investigated with a focus on the ubiquitin ligase RNF8.
I are also interested in the possibility that phosphorylation of E2F1 at
serine 31 by the ATM kinase regulates function of E2F1 in DNA double-strand
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break repair. Our hypothesis is that this phosphorylation event turns E2F1 into
DNA repair protein as well as a transcriptional regulator in response to DNA
damage. As a matter of fact, our lab previous data already demonstrated that
serine 31 phosphorylation is required for ability of E2F1 to repair UV-induced
DNA damage. On the other hand, the DNA-binding domain and transactivation
domain of E2F1 are dispensable for DNA repair despite the fact that they are
essential components for transcription. Inspired by the these findings, the role of
E2F1 serine 31 in maintaining genomic stability and promoting double-strand
break repair will also be explored. Our lab generated a knock-in mouse model in
which E2F1 sequences encoding serine 31 (29 in mouse) were altered to encode
alanine (S29A). This will be a very helpful tool for studying the role of
phosphorylation of serine31 of E2F1 in the DNA damage.
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3.2 Materials and methods
3.2.1 Cell culture
MAFs were isolated from E2f1 knockout and wild type mice and cultured as
described in chapter 2. Primary mouse embryos fibroblasts (MEFs) were isolated
from 12.5 to 13.5 postcoitum (p.c.) mouse embryos. The embryos are
dissociated in sterile PBS then head and internal organs of embryos were
removed for genotyping. The embryo carcasses were minced with curved
scissors and then trypsinized to produce single-cell suspensions. Each cellular
suspension was pipetted and passed through a cell strainer (70 micron) to be
transferred into a 100 mm plate. MEFs were incubated in DMEM supplemented
with 10% FBS. Normal human fibroblasts (NHFs) were obtained from Coriell
Institute were maintained in DMEM supplemented with 10% FBS. The HCT116
colon carcinoma cell line was obtained from ATCC and cultured in McCoy’s 5A
medium (Gibco) with 10% FBS.
3.2.2 Small interference RNA
siRNAs for E2F1 and control are obtained from Santa Cruz. Transfection
was performed by standard methods using Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA).
3.2.3 Western blot
The antibodies used for western blot analysis are total NBS1, pNBS1 ser343,
SMC1 (Cell signaling), pATM ser1981 (Rockland), γH2AX (Millipore), total Chk1
(Santa Cruz), pChk1 ser345 (Santa Cruz), β-tubulin (Santa Cruz), and Rad51
(Santa Cruz).
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3.2.4 Immunofluorescence staining
Co-localization of proteins in response to DNA double-strands breaks and
foci formation detection were performed as described in Chapter 2.
3.2.5 Quantitative RT-PCR
MAFs isolated from E2f1 knockout and wild type mice were treated or
untreated with 5 Gy IR then harvested post one h of treatment. Total RNA of
each sample was isolated using the RNeasy kit (Qiagen, Inc., Valencia, CA,
USA). The RNA was quantified with Nanodrop and 20 ng of total RNA were
applied for the one-step real time reverse-transcriptase PCR assays with an ABI
Prism 7700 (Applied Biosystems, Foster City, CA) instrument. Probes and
primers were adopted from the mouse Rad51 assay provided by the Applied
Biosystems (Mm01337943_m1). The reactions were designed according to the
manufacturer's instructions, with a 30-minute of reverse transcription step
followed by amplification with annealing temperature at 60°C. The PCR product
is 106 bps. The level of Rad51 is calculated with comparative CT methods, with
normalization to the housekeeping gene GAPDH level. The untreated controls
serve as the reference group (designated as 1.0). All groups were assayed in
triplicate.
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3.3 Results
3.3.1 NBS1 foci formation in response to DNA double-strand breaks is
dependent on E2F1
The MRN complex is involved in ATM activation in response to doublestrands break as well as DNA end resection, which is important for both NHEJ
and HR. MRN components, such as NBS1, are some of the earliest proteins
recruited to the sites of DNA double-strand breaks. To investigate whether E2F1
status would affect NBS1 recruitment to sites of DNA double-strand breaks,
NBS1 foci formation was examined by IF in E2f1 wild type and knockout MAFs.
The result showed that in response to IR- induced DNA double-strand breaks,
NBS1 formed multiple foci in wild type cells but foci formation was impaired
significantly in cells lacking E2F1 (Figure 3.1A). Approximately 60% of wild type
cells showed NBS1 foci formation while only 20% cells displayed NBS1 foci
formation in the absence of E2F1 (Figure 3.1B). Consistent with previous result,
γH2AX foci formation appeared to increase in the absence of E2F1.
Western blot analysis was also performed to determine if NBS1 expression
levels are affected by the absence of E2F1. The total protein level of NBS1 was
the same in MAFs with or without E2F1 and NBS1 protein levels showed no
change in response to DNA damage (Figure 3.2). As I speculated, NCS
treatment, which induces double-strand breaks, lead to autophosphorylation and
activation of ATM in both wild type and E2f1-/- MAFs. In contrast, hydroxyurea
(HU) treatment, which induces replication stress and activates ATR, did not
cause autophosphorylation of ATM. Consistent with this, activated ATM
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phosphorylated NBS1 on its target site in response to NCS treatment but HU
treatment did not in wild type MAFs. Interestingly, I observed that NBS1
phosphorylation in response to NCS treatment was impaired in MAFs lacking
E2F1.
To further confirm these findings, I used short interfering RNA (siRNA) to
deplete E2F1 in normal human fibroblasts (NHFs) and then examined NBS1 foci
formation and protein expression levels in these cells. Control or E2F1 siRNA
was applied to NHFs for 48 hours, then cells were treated with IR or NCS to
induce DNA double-strand breaks. IF results showed that either IR or NCS
treatment produced bright foci formation in NHFs transfected with control siRNA
but not NHFs transfected with E2F1 siRNA (Figure 3.3A). NBS1 foci formation
decreased from around 80∼90% to 20∼30% in cells with E2F1 compared to cells
lacking E2F1 (Figure 3.3B). This observation is similar to the finding in MAFs
lacking E2F1. Cells knocked down for E2F1 displayed enhanced γH2AX foci
formation consistent with our previous finding in chapter 2 that E2F1 absence
causes enhanced γH2AX foci.
Western Blot analysis indicated that E2F1 depletion did not affect total NBS1
protein levels either with or without IR treatment (Figure 3.4). However,
consistent with what was observed in E2f1-/- MAFs, E2F1 knock down impaired
NBS1 phosphorylation after IR treatment in NHFs.
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Figure 3.1 Lack of E2F1 impairs NBS1 foci formation in response to DNA
damage.
A. Primary wild type and E2f1 knockout MAFs were untreated or treated with 2
Gy of IR. After exposure to IR, cells were incubated for one h before performing
IF staining with NBS1 and γH2AX antibodies. DAPI was used as a counterstain.
Reproduced from (Chen,J, Cell Cycle 10:1287-1294.), with permission from
Landes Bioscience.
B. The percentage of cells displaying NBS1 foci was determined by counting 100
cells for each genotype using IF images from three independent experiments.
*indicates statistically significant difference (p<0.05). Reproduced from (Chen,J,
Cell Cycle 10:1287-1294.), with permission from Landes Bioscience.
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Figure 3.2 Lack of E2F1 impairs NBS1 phosphorylation in response to DNA
damage.
Primary wild type and E2f1 knockout MAFs were untreated or treated with HU
(1.5 ng/ml) or NCS (50 ng/ml) for one hour. Whole cell extract was harvested for
western blot analysis. The antibodies used in this experiment are: phospho-ATM
antibody at serine 1981 site, total NBS1 antibody, phospho-NBS1 antibody at
serine 343 site, and total SMC1 antibody as loading control. Reproduced from
(Chen,J, Cell Cycle 10:1287-1294.), with permission from Landes Bioscience.
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Figure 3.3 E2F1 deficiency impairs NBS1 foci formation in response to DNA
damage in human cells.
A. NHFs were transfected with E2F1 siRNA or control siRNA. 48 h after
transfection, cells were untreated or exposed to 10 Gy of IR or NCS (50 ng/ml)
for 15 min. After incubation for one h, cells were used to perform IF staining with
NBS1 and γH2AX antibodies. DAPI was used as a counterstain. Reproduced
from (Chen,J, Cell Cycle 10:1287-1294.), with permission from Landes
Bioscience.
B. The percentage of cells displaying NBS1 foci was determined by counting 100
cells for each genotype using IF images from three independent experiments.
*indicates statistically significant difference (p<0.05). Reproduced from (Chen,J,
Cell Cycle 10:1287-1294.), with permission from Landes Bioscience.
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Figure 3.4. E2F1 deficiency impairs NBS1 phosphorylation in response to
DNA damage in human cells.
NHFs were transfected with E2F1 siRNA or control siRNA. 48 h after
transfection, cells were untreated or exposed to 10 Gy of IR and then incubated
for one h. Whole cell extract was used for western blot analysis using antibodies
for: total E2F1, total NBS1, phospho-NBS1 at serine 343 site and total SMC1.
Reproduced from (Chen,J, Cell Cycle 10:1287-1294.), with permission from
Landes Bioscience.
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3.3.2 E2F1 promotes foci formation of RPA at sites of double-strand
break
Single-strand DNA is created at sites of DNA double-strand break by MRNdependent end processing, which is required for both microhomology-mediated
end joining and homologous recombination (139, 140). This single stranded DNA
is stabilized by binding of the three subunits factor replication protein A (RPA).
Since E2F1 absence could impair NBS1 foci formation at DNA double-strand
break sites, I wondered whether E2F1 could also affect MRN-mediated DNA end
processing and the generation of single- stranded DNA. To determine this, IF
staining was performed in wild type and E2f1-/- MAFs treated with IR and NCS to
generate DNA double-strand break. I observed that RPA formed robust foci in
wild type MAFs but RPA foci formation was significantly impaired in cells lacking
E2F1 (Figure 3.5A). Image analysis showed that while most wild type cells
treated with IR generate greater than 10 RPA foci per cell, around 70% of E2f1-/MAFs displayed no RPA foci formation after IR treatment (Figure 3.5 A).
Western blot analysis was performed to determine if E2F1 affected RPA
protein levels. Like NBS1, E2F1 absence does not affect RPA protein levels,
before or after damage. This indicates that E2F1 affects RPA localization to sites
of DNA double-strand break and suggests E2F1 is important for MRN-dependent
DNA end processing.
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Figure 3.5 The absence of E2F1 impairs RPA foci formation in response to
DNA damage.
A. Primary wild type and E2f1 knockout MAFs were untreated or treated with 10
Gy of IR or NCS (50 ng/ml) then incubated for one h. After treatment, cells were
immunofluorescently stained for the RPA2 protein. DAPI was used as a
counterstain. Reproduced from (Chen,J, Cell Cycle 10:1287-1294.), with
permission from Landes Bioscience.
B. IF images were analyzed using the FociCounter software program. The
percentage of cells presenting different foci number was calculated after scoring
more than 55 cells for each genotype in three independent experiments.
*indicates statistically significant difference (p<0.05). Reproduced from (Chen,J,
Cell Cycle 10:1287-1294.), with permission from Landes Bioscience.
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Figure 3.6 The absence of E2F1 does not affect RPA protein levels.
Primary wild type and E2f1 knockout MAFs were untreated or treated with 10
Gy of IR or NCS (50 ng/ml) then incubated for one h. Whole cell extracts were
harvested for western blot analysis using RPA2 antibody and actin antibody as a
loading control. Reproduced from (Chen,J, Cell Cycle 10:1287-1294.), with
permission from Landes Bioscience.
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3.3.3 E2F1 promotes Rad51 foci formation at the sites of double-strand
breaks.
Rad51 is the main recombinase in homologous recombination (HR) repair of
DNA double-strand breaks. Rad51 is involved in the homology searching and
DNA strand pairing stages of the homologous recombination process. Rad51
interacts with the single-strand DNA-binding RPA factor and displaces it on
single-stranded DNA in a process requiring BRCA2 (141, 142).
Using IF I observed that Rad51 foci brightness and foci number in each cell
was reduced significantly in cells lacking E2F1 compared to wild type cells
following IR treatment. In contrast, foci formation of another DNA double-strand
break response factor, 53BP1 was unchanged without E2F1 (Figure 3.7).
Western blot analysis showed Rad51 protein levels increased in response to IR
or NCS treatment, and this was impaired in cells lacking E2F1 (Figure 3.8).
However, Rad51 mRNA levels did not change following DNA damage with or
without E2F1 (Figure 3.9). This indicates that the E2F1-dependent increase
Rad51 protein levels in response to DNA damage is not due to transcriptional upregulation.
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Figure 3.7 Knock down of E2F1 impairs Rad51 foci formation in response
to DNA damage.
NHFs were transfected with E2F1 siRNA or control siRNA. 48 hours after
transfection, cells were treated with 10 Gy of IR and then incubated for one h. IF
staining was performed using Rad51 and 53BP1 antibodies. DAPI was used as a
counterstain. Reproduced from (Chen,J, Cell Cycle 10:1287-1294.), with
permission from Landes Bioscience.
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Figure 3.8 The absence of E2F1 impairs the increase in Rad51 protein
levels in response to DNA damage.
Primary wild type and E2f1 knockout MAFs were untreated or treated with 5
Gy of IR or NCS (50 ng/ml) and then incubated for one h. Whole cell extracts
were used for western blot analysis using Rad51 antibody and β-tubulin antibody
as a loading control. Reproduced from (Chen,J, Cell Cycle 10:1287-1294.), with
permission from Landes Bioscience.
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Figure 3.9 The absence of E2F1 does not affect Rad51 mRNA levels.
Primary wild type and E2f1 knockout MAFs were untreated or treated with 10
Gy of IR and then incubated for one h. Cells were harvested, RNA extracted, and
the mRNA level for Rad51 was determined by real-time PCR. Reproduced from
(Chen,J, Cell Cycle 10:1287-1294.), with permission from Landes Bioscience.
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3.3.4 Absence of E2F1 affects phosphorylation of Chk1 in response to DNA
double-strand breaks.
It is reported that RPA-covered single-stranded DNA (RPA-ssDNA)
generated at sites of DNA damage is involved in the activation of ATR-Chk1
signaling (143). To further confirm our findings that the absence of E2F1 impairs
DNA

end

resection in

response

to double-strand

breaks,

I

checked

phosphorylation of Chk1 by western blot. I used siRNA to deplete E2F1 in NHFs
and then examined Chk1 protein expression levels and phosphorylation in these
cells. Western Blot analysis indicated that E2F1 depletion did not affect total
Chk1 and SMC1 protein levels either with or without IR treatment (Figure 3.10).
However, E2F1 knock down impaired Chk1 phosphorylation at serine 345 site
after IR treatment in NHFs. This finding is consistent with our conclusion that
E2F1 is important for DNA end resection and formation of single-stranded DNA
at site of double-strand breaks.
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Figure 3.10 The absence of E2F1 affects phosphorylation of Chk1.
Chk1
HFs were transfected with E2F1 siRNA or control siRNA. 48 h after
NHFs
transfection, cells were untreated or exposed to 10 Gy of IR and then incubated
for one h. Whole cell extract was used for western blot analysis using antibodies
for: total E2F1, total Chk1, phospho
phospho-Chk1
Chk1 at serine 345 site and total SMC1.
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3.3.5 The absence of E2F1 impairs GCN5 foci formation in response to DNA
damage.
Our previous work demonstrated that E2F1 associates with GCN5 and
recruits GCN5 to sites of UV-induced DNA damage (144) E2F1-dependent
recruitment of GCN5 is associated with increased H3K9 acetylation at sites of UV
damage and enhanced recruitment of DNA repair factors, including XPC and
XPA.
To investigate whether E2F1 recruits GCN5 to sites of DNA double-strand
breaks, the ability of GCN5 to form foci was examined by IF in wild type and E2f1
knockout MAFs. The result showed that in response to IR-induced DNA doublestrand breaks, GCN5 formed multiple foci in wild type cells. However, GCN5 foci
formation was significantly impaired in cells lacking E2F1 (Figure 3.10A). Around
70% of wild type cells showed GCN5 foci formation while fewer than 20% cells
lacking E2F1 displayed GCN5 foci (Figure 3.10B). In contrast, γH2AX foci
formation increased in the absence of E2F1 as previously observed.
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Figure 3.11 The absence of E2F1 impairs GCN5 foci formation in response
to DNA damage.
A. Primary wild type and E2f1 knockout MAFs were untreated or treated with 5
Gy of IR and then incubated for one h. Cells were IF stained for GCN5 and
γH2AX. DAPI was used as a counterstain.
B. Images were analyzed by foci counting. The percentage of cells presenting
different foci number was calculated after scoring more than 100 cells for each
genotype under microscope. *indicates statistically significant difference
(p<0.05).
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3.3.6 Mouse E2F1 serine 29 is required for the accumulation of E2F1 at
sites of DNA double-strand breaks.
As a tool for studing the role of E2F1 in the DNA damage response, Ihave
generated a knock-in mouse model in which E2F1 sequences encoding serine
29, which is equivlent to human E2F1 serine 31, were altered to encode alanine
(S29A). Lines from two independent ES cell clones have been generated and
heterozygous mice were crosed to generate E2f1S29A/S29A homozygous knock-in
mice.
MEFs were generated from E2f1S29A/S29A and wild type sibling embryos and
were used to examine E2F1 expression and localization in response to IR. As
predicted, expression of E2F1 was decreased in E2f1S29A/S29A cells compared to
wild type cells following IR treatment (data not shown). IF staining showed that
E2F1 foci formation in response to IR was impaired in S29A mutant cells (Figure
3.11). Moreover, primary keratinocytes from E2f1S29A/S29A

mice displayed

increased levels of spontaneous breaks, similar to E2f1-/- mice (Figure 3.12). In
addtion, NBS1 foci formation was significantly impaired in E2f1S29A/S29A MEFs just
like in E2f1-/- MEFs (Figure 3.13). Taken together, these findings indicate the
S29A knock-in mutation leads to many of the same cellular phenotypes observed
as when E2f1 is knocked out.
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Figure 3.12 S29A mutantion of mouse E2F1 impaires its localization to
DNA double-strand break sites.
A. Primary wild type and E2F1 S29A mutant MEFs were untreated or treated with
5 Gy of IR and then incubated for one h. Cells were IF stained using E2F1
antibody. DAPI was used as a counterstain.
B. Images were analyzed by foci counting. The percentage of cells presenting
different foci number was calculated after scoring more than 100 cells for each
genotype.
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Figure 3.13 S29A mutantion of E2F1 leads to accumulation of endogenous
DNA damage.
Primary keratinocytes were isolated from wild type, E2f1S29A/S29A and E2f1-/mice and subjected to the comet assay. The average Olive moment was
calculated from 70 cells per genotype in three independent experiments.
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Figure 3.14 The E2F1 S29A mutation impairs NBS1 foci formation in
response to IR
A. Primary wild type and E2f1S29A/S29A MEFs were untreated or treated with 5 Gy
of IR. After exposure to IR, cells were incubated for one h and used to perform IF
staining with NBS1 and γH2AX antibodies. DAPI was used as a counterstain.
B. The percentage of NBS1 cells displaying foci was calculated by analyzing IF
images as in A. The result was determined for 100 cells for each genotype from
three independent experiments. *indicates statistically significant difference
(p<0.05).
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3.4 Discussion
The E2F1 protein is now known to play important roles in the response to
DNA damage. Other reports demonstrated that E2F3, E2F7 and E2F8 are also
involved in the DNA damage response, but E2F1 is indispensible for their
functions (145, 146). The mechanisms underlying a role for E2F1 in the DNA
damage response, which may be related to its function in tumor suppression, are
controversial and require detailed investigation.
Here I have clearly demonstrated that E2F1 contributes to genome
stability and DNA double-strand break repair by monitoring γH2AX levels and
DNA breaks by the comet assay. However, the mechanism by which E2F1
regulates DNA repair has been debated. Some groups found that E2F1
transcriptionally up-regulates the DDB2 protein and/or XPC protein in response
to UV-induced DNA damage, while other groups have demonstrated that E2F1 is
also responsible for transcription of genes for homologous recombination repair,
mismatch repair and base excision repair (147-151). While the significance of
transcriptional regulation by E2F1 cannot be underestimated for apoptosis
induction, the role of E2F1-mediated transcriptional regulation in DNA repair is
unclear. Most of the genes for DNA repair mentioned above are apparently
regulated by other E2F family members as well as other transcription factors,
such as p53, and E2F1 has not been shown to be the dominant player in their
regulation network (152). In addition, the modest upregulation of these DNA
repair genes in response to damage is delayed compared to the more rapid
effects of E2F1 status on NER factor recruitment and repair, which occur within
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one hour. More importantly, I also demonstrated that mutation of the DNA
binding domain or deletion of transactivation domain of E2F1 does not affect its
ability to stimulate repair of UV-induced damage (118). Therefore, I examined
potential non-transcriptional functions of E2F1 in DNA double-strand break
repair.
First, I investigated which portion of the DNA damage response pathway
is affected by the absence of E2F1. Although the level of phospho-ATM is not
changed in E2f1 knockout primary fibroblasts, NBS1, an essential component of
the MRN complex, requires E2F1 for its ability to form foci at sites of DNA
double-strand breaks. This phenomenon was confirmed in normal human
fibroblasts depleted of E2F1 by specific small interference RNA. I also observed
that phosphorylation of NBS1 is significantly decreased in the absence of E2F1.
Previous studies have shown that NBS1 was phosphorylated by the ATM kinase
(77, 153). It should be noted that total levels of NBS1 are not affected by the
absence or knockdown of E2F1, indicating that E2F1 is involved in DNA doublestrand break repair in a transcription-independent manner.
I then examined how E2F1 affects the recruitment of other DNA repair
proteins in addition to NBS1. I found that RPA2 foci formation in response to
DNA double-strand breaks is also significantly impaired in the absence of E2F1.
As the coating protein for exposed single-stranded DNA, RPA foci formation
serves as a marker for DNA end resection at DNA double-strand breaks. At the
same time, I did not observe any change in total RPA2 protein level by western
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blot in the presence or absence of E2F1, which indicates that E2F1 affects RPA
foci formation independent of its transcriptional regulation.
I also studied Rad51, the DNA recombinase that is essential for the final
steps of homologous recombination. Localization of Rad51 to sites of DNA
damage is one of the most important indicators of functional homologous
recombination repair (154). In E2f1 knockout cells, Rad51 foci formation is
significantly impaired.

However, 53BP1, another common marker of DNA

double-strand breaks, still forms foci in response to DNA damage despite the
absence of E2F1. I also observed that the protein levels of Rad51 are
dramatically increased in response to DNA damage in wild type cells, possibly
indicating DNA damage related protein stabilization, which is significantly
impaired in the E2f1 knockout cells. However, it should be noted that the basal
levels of Rad51 before induction by DNA damage are very low in both wild type
and E2f1 knockout cells, indicating that E2F1 is not involved in the basal
transcription of Rad51. Although another report suggested that E2F1 might be
the major transcription factor for Rad51 gene expression (155), our finding with
quantitative RT-PCR analysis of wild type and E2f1 knockout cells did not reveal
any difference in the levels of Rad51 mRNA, both before and after DNA doublestrand break induction. The impaired increase in Rad51 protein levels following
DNA double-strand break induction in cells lacking E2F1 is most likely due to an
unknown mechanism that affects the protein stability of Rad51. Further
investigation will be necessary to answer this intriguing question.
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To further confirm that depletion of E2F1 affects DNA end resection, I also
examined Chk1 phosphorylation, which is a downstream event of ATR signaling
activated by RPA-covered single-stranded DNA. The phosphorylation level of
Chk1 at serine 345 decreased significantly in E2F1 knockdown NHFs compared
to control NHFs after IR treatment while the total Chk1 level did not change. This
result further supports that E2F1 status affects recruitment of DNA repair
proteins, especially DNA end resection factors, to sites of DNA double-strand
breaks.
Since I have observed that several key steps of DNA double-strand break
repair are regulated by E2F1, the underlying mechanism for this regulation is
very meaningful. As mentioned previously, chromatin modification plays critical
roles in the signal transduction of the DNA damage response, and our previous
study has shown a role for E2F1 in histone acetylation following UV irradiation.
With this in mind, I examined the localization of several chromatin modifiers that
may serve as partners of E2F1 in chromatin modification at sites of DNA doublestrand breaks, including Tip60, TRRAP, RNF8 (data not shown) and GCN5.
Among these proteins, only localization of GCN5 to sites of DNA damage was
found to be significantly impaired in the absence of E2F1, which was decreased
by more than 3-fold. This is consistent with our findings in the UV damage
response, where I found that E2F1 recruits GCN5 leading to histone H3 lysine 9
acetylation at local areas of DNA damage. However, I was unable to detect
localization of acetylated H3 lysine 9 at sites of DNA double-strand breaks by
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immunostaining. Further studies will be necessary to investigate the specific
chromatin changes at sites of DNA double-strand breaks regulated by E2F1.
How protein modifications regulate the functions of E2F1 in response to
DNA double-strand breaks is also a critical question to address. It has been well
documented that E2F1 is phosphorylated at serine 31 by ATM or ATR in
response to different types of DNA damage. In response to UV damage, it
appears that ATR is the major player, while ATM is more important in the
response to DNA double-strand breaks. Under either circumstance. E2F1 can be
recruited to sites of DNA damage. While the role of E2F1 in UV damage repair
has been well demonstrated, its function at sites of double-strand breaks is still
not elucidated. Another group showed that E2F1 is recruited to sites of DNA
double-strand breaks through a phospho-specific interaction with TopBP1. Here I
confirmed that E2F1 serine 29 in mouse, which is equivalent to human serine 31,
is indeed required for localization of E2F1 to sites of DNA double-strand breaks
as mutation of serine 29 leads to a significant decrease in E2F1 foci formation. In
addition, S29A knock-in primary mouse fibroblasts displayed significantly
impaired NBS1 foci formation compared to the wild type cells, indicating that
serine 29 phosphorylation is important for the function of E2F1 in DNA repair.
This is consistent with our results that serine 29 knock-in primary mouse
fibroblasts showed significantly increased levels of spontaneous DNA breaks as
demonstrated by the comet assay. These findings support the hypothesis that
ATM-mediated phosphorylation of E2F1 is required for its localization to sites of
DNA double-strand breaks as well as its functions in DNA repair.
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Overall, I have shown that E2F1 is involved in the DNA double-strand
break response and important for maintaining genome stability. E2F1 status
affects NBS1, RPA and Rad51 foci formation, the phosphorylation of NBS1 and
Rad51 protein stabilization in response to DNA damage. This appears to be
achieved in a transcription-independent manner and may involve GCN5 as a
partner of E2F1. The role of chromatin modifications, such as histone
acetylation, requires further investigation. In addition, I provide evidence to
support the hypothesis that the phosphorylation of E2F1 serine 31 (29 in mouse)
by the ATM kinase is a critical event that brings E2F1 to sites of DNA damage
and is required for proper regulation of DNA repair.
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Chapter 4. Summary and future directions
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4.1 Summary
E2F1 possesses the ability to promote cell cycle progression and cell
survival, as well as apoptosis induction and DNA repair. The role of E2F1 in
tumor development is complex and context-dependent. In this thesis, I reveal
novel roles for E2F1 in response to DNA double-strand breaks that may have
important implications for tumor suppression. It was demonstrated that E2F1
protein levels increase after DNA damage, which involves serine 31
phosphorylation event by the ATM or ATR kinase. Furthermore, it was also
shown that this phosphorylation is required for E2F1 binding to TopBP1, which
suppresses apoptosis by inhibiting E2F1 transcriptional activity. TopBP1 binding
also recruits E2F1 to sites of DNA double-strand breaks to form foci that colocalize with other DNA double-strand break markers such as γH2AX. Moreover,
in my previous project, I showed that E2F1 is recruited to UV-induced DNA
damage and directly affects the local chromatin structure by recruiting GCN5 and
promoting histone H3 acetylation at lysine 9 specifically, which may regulate the
accessibility of the DNA repair machinery. This function in UV damage repair is
entirely transcription-independent and serine 31 phosphorylation is critical for
this repair activity. Based on the data above, I hypothesize that E2F1 may also
promote DNA double-strand break repair through a transcription-independent
mechanism.
To test the efficacy of the above hypothesis, I examined the role of E2F1
in the maintenance of genomic integrity and DNA double-strand break repair. In
support of our hypothesis, I observed significant chromosomal abnormalities in
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primary keratinocytes and spontaneous DNA damage in primary fibroblasts from
E2f1 knockout mice, indicated by γH2AX immunofluorescence staining and the
comet assay. This is a common feature of cells lacking “caretaker” genes, which
are important for genomic stability and play critical roles in DNA repair (156). I
confirmed this assumption using both the comet assay for DNA breaks removal
and examination of γH2AX levels after ionizing radiation, which indicated
significantly delayed repair in E2f1 knockout primary fibroblasts. Therefore, I
speculate that E2F1 functions in the repair of DNA double-strand breaks to
maintain genomic stability, which may relate to its role in tumor suppression.
Since I have found that E2F1 contributes to DNA double-strand break
repair, I wanted to explore the underlying mechanism. NBS1, as part of the MRN
complex, is one of the first proteins to be recruited to sites of double-strand
breaks and participates in both NHEJ and HR. I identified that phosphorylation
and foci formation of NBS1 in response to DNA double-strand breaks is
significantly impaired in E2F1 knock down or knockout cells, while the total
protein levels of NBS1 are not affected. Likewise, RPA foci formation but not
RPA protein levels, was also impaired by E2F1 deficiency. To examine a further
downstream component of DNA double-strand break repair, I looked at Rad51
foci formation, since Rad51 is the major recombinase for the process of
homologous recombination. I found that Rad51 foci formation was also impaired
in the absence of E2F1. Interestingly, I observed decreased Rad51 protein levels
in E2f1 knockout cells but quantitative RT-PCR did not reveal any difference in
Rad51 mRNA levels between wild type and E2f1 knockout cells, suggesting that
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E2F1 affects post-translational regulation of the Rad51 protein. I also found
E2F1 deficiency affects phosphorylation of Chk1 by ATR, which requires
recruitment of the ATR-ATRIP complex to RPA coated single-stranded DNA. All
of these results point to a role for E2F1 in DNA end resection and the formation
of single-stranded DNA at sites of double-strand breaks.
To further investigate the mechanism how E2F1 affects these DNA
damage response factors, I demonstrated that the histone acetyltransferase
GCN5 is recruited to sites of DNA double-strand breaks and loss of E2F1
significantly decreases GCN5 foci formation, which is similar to what was
observed in the response to UV damage. However, further studies are required
to reveal the role of GCN5 in E2F1-mediated repair of DNA double-strand
breaks.
I have also hypothesized that serine 31 phosphorylation of E2F1 is the
major signal for E2F1 to act as a DNA repair protein instead of a transcription
factor. While this theory was confirmed for UV-induced DNA damage repair (134)
and suggested for double-strand break repair by other studies (113). I performed
a more thorough investigation and found that phosphorylation of E2F1 serine 31
(serine 29 in mice) is required for both its recruitment to sites of DNA doublestrand breaks and its functions in DNA repair using cells from a novel E2f1 S29A
knock-in mouse model. In particular, I find that E2f1 S29A knock-in cells display
a similar extent of decreased NBS1 foci formation as well as genomic stability,
comparable to E2f1 knockout cells.
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Taken together, I conclude that E2F1 regulates the recruitment and/or
retention of several proteins at sites of double-strand breaks to contribute to
DNA repair. This may involve the modification of chromatin structure by GCN5 or
other chromatin modifiers. In addition, serine 31/29 phosphorylation of E2F1 is a
critical upstream regulatory event for E2F1 to function in the DNA damage
response. Overall, this novel function in directly regulating DNA double-strand
break repair is likely important to maintain genomic stability, which may explain
how E2F1 functions as a tumor suppressor.
4.2 Future directions
Various cancer therapeutic agents function through DNA damage induction
especially causing DNA double-strand breaks. Comprehensive understanding of
the underlying mechanisms of the response to these agents can help us tailor
more effective treatment strategies. Therefore it will be of great significance to
further uncover the novel role of E2F1 in the DNA damage response. I propose
that the following areas of research will benefit further advances of this project.
• Detailed mechanisms underlying regulation of NBS1 by E2F1 in the
DNA double-strand break response
• Functions of E2F1 in end resection and homologous recombination
repair
• Detailed mechanisms underlying regulation of GCN5 by E2F1 in the



DNA double-strand break response
• In vivo Investigations of the S29A knock-in mouse model
These areas will be elaborated in details as follows.
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4.2.1 Detailed mechanisms underlying regulation of NBS1 by E2F1 in the
DNA double-strand break response
As discussed in Chapter 1, MDC1 is recruited to DNA double-strand break
sites by directly binding to γH2AX. This event recruits the E3 ligase RNF8, which
in turn recruits RNF168, another E3 ligase that further amplifies ubiquitylation of
the histone H2A to generate uH2A for the accessibility of DNA repair machinery.
In particular, RNF168 is important for the recruitment of BRCA1 through the
ubiquitin-binding protein Rap80 and ABRA1(85). Therefore, it will be interesting
to know whether E2F1 deficiency affects recruitment of MDC1, RNF8 and
RNF168 to DNA double-strand breaks. An important control for these
experiments is to determine if E2F1 deficiency affects the expression level of
these proteins by western blot analysis. If MDC1 levels are unaffected by E2F1
deficiency but recruitment to sites of DNA double-strand breaks is impaired, this
could indicate that MDC1 is unable to gain access to γH2AX since H2AX
phosphorylation is normal or even higher in E2F1 deficient cells. If MDC1 is
recruited to sites of DNA double-strand breaks but NBS1 and RNF8 are not
(even through they are expressed normally), then this would imply that NBS1
and RNF8 associations with MDC1 are regulated by E2F1.
It will also be necessary to examine whether these factors affect the
interaction between E2F1 and NBS1 if they function upstream of the pathway.
The potential impact of E2F1 on MDC1-NBS1 and MDC1-RNF8 interactions
should be investigated as well. Whether E2F1 status affects the formation of
uH2A will provide direct evidence that E2F1 plays a role in chromatin
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modification in response to DNA damage. The results provided from the above
experiments can potentially provide the crucial information for our findings of
impaired DNA double-strand break repair in cells lacking E2F1.
Primary cells isolated from E2f1

S29A/S29A

mice can be used to examine

whether the serine 29 mutation causes the same effects as E2F1 knockout in
response to IR or other DNA double-strand break inducing agents. Our
preliminary data has already shown that NBS1 foci formation is impaired in E2f1
S29A/S29A

cells similar to E2f1 knockout cells. Future experiments can investigate

whether E2F1 serine 29 mutation also affects Rad51 and RPA recruitment to
DNA double-strand break sites by both IF staining and a well-controlled DNA
double-strand break generating system developed by the Kastan group (77).
Briefly, this group developed an ER-I-Ppol/ChIP assay, which introduces the
inducible expression of a rare cutting endonuclease in cells to create DNA
double-strand break at specific loci in the genome. A ChIP assay can then
identify histone modifications and proteins that are recruited to sites of doublestrands break.
Recently, Komatsu’s group reported NBS1 could recruit Rad18 and regulates
translesion DNA synthesis (TLS) (157). This raises the possibility that E2F1
affects NBS1 and Rad18 in TLS besides homologous recombination repair to
facilitate maintenance of genome stability. It will therefore be interesting to
examine whether E2F1 status also affects recruitment of Rad18 and TLS to sites
of double-strand breaks.
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4.2.2 Functions of E2F1 in end resection and homologous recombination
repair
In my study, I presented evidence that E2F1 affects l DNA end resection at
DNA double-strand break sites. To further understand this pathway, it will be
beneficial to examine effects of E2F1 on the subcellular localization and
activation of other essential homologous recombination repair factors, such as
BRCA1, BRCA2 and Rad52. In addition, it will be critical to know whether the
status of E2F1 eventually affects homologous recombination repair efficiency.
Southern blotting is a traditional way to evaluate homologous recombination
repair efficiency. An I-Scel-based homologous recombination assay measured
by random-plasmid integration will also be a good tool to detect homologous
recombination repair (158).
If the above results are confirmed, further study in experimental animal should
be applied. A C57BL/6J pun/un mouse model was established for measuring the
frequency of homologous recombination in vivo (159). The murine pigmentation
(p) gene is normally transcribed in melanocytes and cells of the RPE. The
duplication allele, called pink-eyed unstable (pun), interrupts the p gene and leads
to pink eyes and visible fur-spots in the mice. Homologous recombination events
are required for accurate p gene reconstitution. Bishop et al has successfully
investigated the roles of BRCA1 and Blm, which are two homologous
recombination repair factors, in Cre-C57BL/6J pun/un mice (160). Therefore, I can
also utilize this mouse model to detect the role of E2F1 in homologous
recombination repair in vivo in a similar manner by crossing it with wild type, E2f1
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-/-

and E2f1 S29A/S29A mice.
The evaluation of the function of E2F1 in homologous recombination repair

will shed a light on therapeutic strategies in tumors with abnormally low E2F1
expression.
4.2.3 Detailed mechanisms underlying regulation of GCN5 by E2F1 in the
DNA double-strand break response
I proposed that E2F1 promotes H3K9 acetylation at sites of DNA damage by
recruiting GCN5 through direct protein-protein interaction, which probably leads
to chromatin relaxation for the recruitment of DNA repair proteins. Similar to the
cellular response to UV, IR and other agents that induce DNA double-strand
break cause a general relaxation of chromatin that peaks at about 1 hour after
exposure (161, 162). Therefore, it will be interesting to examine a possible role
for E2F1 in modifying chromatin structure in response to DNA double-strand
break.
We could perform an assay to detect a possible interaction between E2F1
and GCN5 in response to DNA double-strand breaks. Following this, we could
examine the possible effects of E2F1 and GCN5 on histone modifications in the
ER-I-Ppol/ChIP assay described previously. By introducing this system into cells
from E2f1-/-, E2f1

S29A/S29A

, and Gcn5hat/hat (cells without GCN5 HAT activity)

mice, I will confirm the recruitment of E2F1 and GCN5 to sites of DNA doublestrand break, as well as the regulation of GCN5 by E2F1. Following that, we can
determine if H3K9 acetylation at sites of DNA double-strand break is dependent
on E2F1 and the HAT activity of GCN5. These cells can also be used to directly
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determine the role of E2F1 and GCN5 in chromatin relaxation in response to IR
by the micrococcal nuclease assay.
To further examine if GCN5 is important for E2F1-dependent processes at
DNA double-stand break, we can examine NBS1, RPA and Rad51 foci formation
and H2A ubiquitination in cells deficient for GCN5. DNA damage repair efficiency
can also be examined in cells lacking GCN5.
4.2.4 In vivo Investigations of the S29A knock-in mouse model
As discussed in the previous chapter, our lab developed an E2f1 serine 29
mutant mouse model to further investigate the significance of E2F1
phosphorylation by ATM in response to DNA double-strand breaks. With this
model, we can determine whether serine 29 phosphorylation is required for the
function of E2F1 in response to IR or other DNA double-strand break inducing
agents in vivo.
First of all, an IR sensitivity experiment can be performed on these mice to
examine the importance of E2F1 in the resistance to DNA damage. Briefly, wild
type and E2f1

S29A/S29A

mice can be exposed to different doses of IR and

monitored for survival as well as tumorigenesis. Some of the mice can be
sacrificed after IR treatment to examine effects on the internal organs. Other
mice can be exposed to low dose IR and observed for lymphomagenesis and
development of other cancers.
In addition, in vivo experiments to study the functions of E2F1 in S29A
mutant in response to oncogenic stress will be of great significance as well. For
this E2f1

S29A/S29A

mice can be crossed with Myc transgenic mice to investigate
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the effects of E2F1 serine 29 mutation on the oncogenic stress response
induced by Myc overexpression. Previous studies in our lab have shown that
transgenic expression of Myc induces DNA damage and activates ATM (129).
Our Previous studies have also demonstrated that the absence of E2F1
accelerated tumor development in the K5 Myc transgenic model. Repeating this
experiment with the E2F1 S29A knock-in model will give more definitive clues
about the significance of E2F1 in the DNA damage response with respect to
tumor suppression.
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